MiniMed Raises $560 Million in US Initial Public Offering

MiniMed raised $560 million in its U.S. initial public offering on Thursday. The diabetes unit of Medtronic announced the pricing of the stock market debut.

Xurve View
Insights:

The diabetes-focused business unit of Medtronic plc, known as MiniMed, has successfully raised $560 million in its initial public offering within the United States. The announcement, made on Thursday, marks a significant milestone for the medical technology company as it seeks to provide its diabetes division with the financial independence necessary to accelerate innovation and market expansion.

An illustration of the Medtronic Plc logo, captured in April 2023. REUTERS/Dado Ruvic/Illustration